Question Title

* 1. Please identify your profession.

Question Title

* 2. Gender?

Question Title

* 3. What is your age range?

Question Title

* 4. Was the content relevant to my practice?

  Not At All Somewhat Very Much N/A
When Issue is the Tissue – Cardiac MRI to the Rescue - Sudarshan Balla, MD, FACC 
How Should My Approach to High Blood Pressure Change?  Key Takeaways from the Guidelines and Case-Based Blood Pressure Pearls - Ty Gluckman MD, FACC, FAHA
Past, Present and Future of Hypertension Devices - Mark Bates MD, FACC, FSCAI, FACP
Lesion Quantification; FFR vs I-FR vs I-VUS vs just “I-Ball” - Anthony J. Roda-Renzelli, MD
Use of mobile health technology and Artificial intelligence in diagnostic cardiology - Partho Sengupta MD, DM, FACC, FSAE
Update on Structural Heart Disease Intervention in 2019 - Aravinda Nanjundappa, MD
Role of Coordinator for Structural Heart Disease - Megan Wood, DNP
Status of Renal Denervation in 2019 for HTN - David Kandzari, MD
Cardiovascular Medication Safety - Sarah Embrey, PharmD
Emerging Role of LAAO Devices in Patients with AFIB - Wissam Gharib MD, FACC, FSCAI
Cardiogenic Shock: State of Art Management - John Gurley, MD, FACC
Myocardial Mechanics: Fundamentals and Clinical Applications - Partho Sengupta MD, DM, FACC, FSAE
Multivessel CAD - Elie Gharib, MD, FACC
Discrepancies in Healthcare Delivery in Southern WV - Frank Annie, PhD (c)
Role of 3D TEE in Cardiovascular Disease Diagnosis - Lavinia Mitulescu, MD
Insight into the Future of ACC - Michael Valentine, MD, FACC
Advantages of Radial Access for Coronary Intervention in 2019 - Jacob Misenheimer MD, FACC
2017 AHA/ACC/HRS Guideline for the Management of Ventricular Arrhythmias and Prevention of SCD: Case Studies - Sana Al-Khatib, MD
Patient Prosthesis Mismatch - Keith Allen, MD
Why Should we Perform CTO Recanulation Percutaneously? - David Kandzari, MD
Submassive Pulmonary Embolism; How Do I Manage? - John Gurley, MD, FACC
Advances in Critical Limb Ischemia - Rameez Sayyed MD
Advances in Endovascular Intervention - James Harman, DO
When to Refer my Patients for AFIB Ablation - Sana Al-Khatib, MD
All Ischemic Heart Disease Benefits from PCI/Stent - Wissam Gharib MD, FACC, FSCAI
CASE STUDY: Sudarshan Balla, MD & Ali Farooq – Constrictive Pericarditis
CASE STUDY: Mark Studeny, MD & Elise Anderson – Complex TAVR
CASE STUDY: Sara Embrey, PharmD & Muhamed Yasin – Cardiogenic Shock
CASE STUDY: Mark Bates, MD, FACC & Ahmed Fatima – Multivessel CAD
CASE STUDY: James Harman, DO & Jason Modor - Case of Stroke
CASE STUDY: Sana Al-Khatib, MD & Vallabh Carpe – What is this EKG?
CASE STUDY: David Kandarzi, MD & Muhamed Adnan – Reninent HTN
CASE STUDY: John Gurley & Elise Anderson – Valve in Valve
CASE STUDY: Wissam Gharib, MD, FACC, FSCAI & Ali Farooq – Can You Close this LAD?

Question Title

* 5. Did the presentations meet your educational needs?

Question Title

* 6. The speaker's had adequate knowledge of subject matters during presentations.

Question Title

* 7. Did you have adequate opportunity to ask questions?

Question Title

* 8. Were the presentations free of commercial bias or influence?

Question Title

* 9. Did information provided improve or build upon your current skills?

Question Title

* 10. Did information provided give new ideas/skills you will use?

Question Title

* 11. Please rate the projected impact of this educational activity on your competence, performance and/or patient outcomes:

  Strongly Disagree Somewhat Disagree Neither Agree nor Disagree Somewhat Agree Strongly Agree
This activity increased my competence.
This activity will improve my performance.
This activity will improve my patient outcomes.

Question Title

* 12. As a team, what will you do differently as a result of attending this program?

Question Title

* 13. What strategies will you share with your team as a result of attending this program?

Question Title

* 14. What topics would you like to see covered at future programs?

Question Title

* 15. What additional skills would you like to develop/learn in the future?

Question Title

* 16. Did you have the opportunity to discuss practice-relevant issues with speakers?

Question Title

* 17. Any perceived barriers in making changes identified?

Question Title

* 18. If yes to question 17, please identify: 

Question Title

* 19. How did you obtain information about this program?

Question Title

* 20. Enter your email to stay up-to-date with ACC WV and Charleston Area Medical Center on conferences and events.

0 of 20 answered
 

T